Analyst consensus rating
Vanda Pharmaceuticals Analyst Rating: none
Direct answer
Vanda Pharmaceuticals's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.19.
Forecast evidence checked September 17, 2026.
Get free Vanda Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $5.00
- Average price target
- $12.19
- High price target
- $20.00
- Low price target
- $5.75
- Low target gap
- +15%
- Target upside
- +143.8%
- High target gap
- +300%
- Target range width
- 285%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 17, 2026
- Valid through
- September 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Vanda Pharmaceuticals?
Vanda Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $12.19.
How far are Vanda Pharmaceuticals's low and high targets from the recorded price?
The low target implies +15%, while the high target implies +300%.
How many analysts are included in Vanda Pharmaceuticals's consensus?
The verified consensus includes 4 analysts.
How is Vanda Pharmaceuticals's target upside or downside calculated?
The average target of $12.19 is divided by the recorded price of $5.00, then one is subtracted to produce +143.8%. This does not guarantee a future return.
When was Vanda Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-17. The dataset is valid through 2026-09-24.